Computer-Aided Drug Discovery Market , By Type (Structure Based Drug Design (SBDD), Ligand-Based Drug Design (LBDD), Sequence-Based Approaches), By Therapeutic Area (Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes), by End-User (Pharmaceutical Companies, Biotechnology Companies, Research Institute), Regional Analysis (North America, Europe, Asia-Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2019–2026
- RES4072114
- 170 Pages
- April 2020
- Healthcare
Huge investments are being done by the key manufacturers in Computer-Aided Drug Discovery market for R&D activities to develop new drugs for various diseases such as cardiovascular diseases and oncology and is expected to drive the global computer-aided drug discovery market in the near future.
Based on Type, the Computer-Aided Drug Discovery market is categorized into Structure Based Drug Design (SBDD), Ligand-Based Drug Design (LBDD) and Sequence-Based Approaches. Ligand-based drug design segment is anticipated to drive the market growth in the recent years and is expected to reach $1,878.2 million growing at a CAGR of 15.2% during the projected time frame.
Computer-Aided Drug Discovery market based on therapeutic area is divided into oncology, neurology, cardiovascular disease, respiratory disease and diabetes among others. Oncology segment held the largest market value accounting for more than $355.8 million in 2018. However, cardiovascular disease segment is expected to boost the global Computer-Aided Drug Discovery market in the recent years and value for $917.2 million in 2018, boosting at a CAGR of 15.8% by 2026.
On the basis of end-user, the computer-Aided Drug Discovery market is segmented into pharmaceutical companies, biotechnology companies and research institutes. Research Institute is expected to lead the market in the year 2018 accounting for $602.3 million and is anticipated to continue its dominance during the forecast period. The research institutes segment is expected to account for $1,873.4 million by 2026 growing at CAGR of % during the forecasted period.
Depending on the region, the market is segregated into North America, Europe, Asia-Pacific and LAMEA. North America region accounted for $432.9 million in 2018 and is estimated to continue its dominance during the forecasted period. This growth is majorly due to the biotechnology and pharmaceutical industry, increased use of personalized medicine, a large number of ongoing drug development processes, and rising R&D expenditure by pharmaceutical and biotechnology companies.
The key market players in Computer -Aided Drug Discovery market include Albany Molecular Research Inc. (AMRI), BioDuro, Charles River, Schrödinger, Aragen Bioscience, Aris Pharmaceuticals, AstraZeneca, BOC Sciences, Evotec A.G., and Bayers AG among many others.
1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters
1.4.1.Assumptions
1.4.2.Forecast parameters
1.5.Data sources
1.5.1.Primary
1.5.2.Secondary
2.Executive Summary
2.1.360° summary
2.2.Type trends
2.3.Therapeutic Area trends
2.4.End-user trends
3.Market overview
3.1.Market segmentation & definitions
3.2.key takeaways
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.3.1.Bargaining power of consumers
3.3.2.Bargaining power of suppliers
3.3.3.Threat of new entrants
3.3.4.Threat of substitutes
3.3.5.Competitive rivalry in the market
3.4.Market dynamics
3.4.1.Drivers
3.4.2.Restraints
3.4.3.Opportunities
3.5.Application landscape
3.6.Regulatory landscape
3.7.Patent landscape
3.8.Market value chain analysis
3.9.Strategic overview
4.Computer-Aided Drug Discovery Market, by Type
4.1.Structure Based Drug Design (SBDD)
4.1.1.Market size and forecast, by region, 2016-2026
4.1.2.Comparative market share analysis, 2018 &2026
4.2.Lignad-Based Drug Design (LBDD)
4.2.1.Market size and forecast, by region, 2016-2026
4.2.2.Comparative market share analysis, 2018 &2026
4.3.Sequence-Based Approaches
4.3.1.Market size and forecast, by region, 2016-2026
4.3.2.Comparative market share analysis, 2018 &2026
5.Computer-Aided Drug Discovery Market, by Therapeutic Area
5.1.Oncology
5.1.1.Market size and forecast, by region, 2016-2026
5.1.2.Comparative market share analysis, 2018 &2026
5.2.Neurology
5.2.1.Market size and forecast, by region, 2016-2026
5.2.2.Comparative market share analysis, 2018 &2026
5.3.Cardiovascular Disease
5.3.1.Market size and forecast, by region, 2016-2026
5.3.2.Comparative market share analysis, 2018 &2026
5.4.Respiratory Disease
5.4.1.Market size and forecast, by region, 2016-2026
5.4.2.Comparative market share analysis, 2018 &2026
5.5.Diabetes
5.5.1.Market size and forecast, by region, 2016-2026
5.5.2.Comparative market share analysis, 2018 &2026
5.6.Others
5.6.1.Market size and forecast, by region, 2016-2026
5.6.2.Comparative market share analysis, 2018 &2026
6.Computer-Aided Drug Discovery Market, by End-user
6.1.Pharmaceutical Companies
6.1.1.Market size and forecast, by region, 2016-2026
6.1.2.Comparative market share analysis, 2018 &2026
6.2.Biotechnology Companies
6.2.1.Market size and forecast, by region, 2016-2026
6.2.2.Comparative market share analysis, 2018 &2026
6.3.Research Institute
6.3.1.Market size and forecast, by region, 2016-2026
6.3.2.Comparative market share analysis, 2018 &2026
7.Computer-Aided Drug Discovery Market, by Region
7.1.North America
7.2.Market size and forecast, by Type, 2016-2026
7.3.Market size and forecast, by Application, 2016-2026
7.4.Market size and forecast, by country, 2016-2026
7.5.Comparative market share analysis, 2018 &2026
7.5.1.U.S.
7.5.1.1.Market size and forecast, by Type, 2016-2026
7.5.1.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.5.1.3.Market size and forecast, by End-user, 2016-2026
7.5.1.4.Comparative market share analysis, 2018 &2026
7.5.2.Canada
7.5.2.1.Market size and forecast, by Type, 2016-2026
7.5.2.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.5.2.3.Market size and forecast, by End-user, 2016-2026
7.5.2.4.Comparative market share analysis, 2018 &2026
7.5.3.Mexico
7.5.3.1.Market size and forecast, by Type, 2016-2026
7.5.3.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.5.3.3.Market size and forecast, by End-user, 2016-2026
7.5.3.4.Comparative market share analysis, 2018 &2026
7.6.Europe
7.6.1.Market size and forecast, by Type, 2016-2026
7.6.2.Market size and forecast, by Application, 2016-2026
7.6.3.Market size and forecast, by country, 2016-2026
7.6.4.Comparative market share analysis, 2018 &2026
7.6.5.UK
7.6.5.1.Market size and forecast, by Type, 2016-2026
7.6.5.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.6.5.3.Market size and forecast, by End-user, 2016-2026
7.6.5.4.Comparative market share analysis, 2018 &2026
7.6.6.Germany
7.6.6.1.Market size and forecast, by Type, 2016-2026
7.6.6.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.6.6.3.Market size and forecast, by End-user, 2016-2026
7.6.6.4.Comparative market share analysis, 2018 &2026
7.6.7.France
7.6.7.1.Market size and forecast, by Type, 2016-2026
7.6.7.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.6.7.3.Market size and forecast, by End-user, 2016-2026
7.6.7.4.Comparative market share analysis, 2018 &2026
7.6.8.Spain
7.6.8.1.Market size and forecast, by Type, 2016-2026
7.6.8.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.6.8.3.Market size and forecast, by End-user, 2016-2026
7.6.8.4.Comparative market share analysis, 2018 &2026
7.6.9.Italy
7.6.9.1.Market size and forecast, by Type, 2016-2026
7.6.9.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.6.9.3.Market size and forecast, by End-user, 2016-2026
7.6.9.4.Comparative market share analysis, 2018 &2026
7.6.10.Rest of Europe
7.6.10.1.Market size and forecast, by Type, 2016-2026
7.6.10.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.6.10.3.Market size and forecast, by End-user, 2016-2026
7.6.10.4.Comparative market share analysis, 2018 &2026
7.7.Asia-Pacific
7.7.1.1.Market size and forecast, by Type, 2016-2026
7.7.1.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.7.2.Market size and forecast, by End-user, 2016-2026
7.7.3.Market size and forecast, by country, 2016-2026
7.7.4.Comparative market share analysis, 2018 &2026
7.7.5.China
7.7.5.1.Market size and forecast, by Type, 2016-2026
7.7.5.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.7.5.3.Market size and forecast, by End-user, 2016-2026
7.7.5.4.Comparative market share analysis, 2018 &2026
7.7.6.Japan
7.7.6.1.Market size and forecast, by Type, 2016-2026
7.7.6.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.7.6.3.Market size and forecast, by End-user, 2016-2026
7.7.6.4.Comparative market share analysis, 2018 &2026
7.7.7.India
7.7.7.1.Market size and forecast, by Type, 2016-2026
7.7.7.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.7.7.3.Market size and forecast, by End-user, 2016-2026
7.7.7.4.Comparative market share analysis, 2018 &2026
7.7.8.Australia
7.7.8.1.Market size and forecast, by Type, 2016-2026
7.7.8.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.7.8.3.Market size and forecast, by End-user, 2016-2026
7.7.8.4.Comparative market share analysis, 2018 &2026
7.7.9.South Korea
7.7.9.1.Market size and forecast, by Type, 2016-2026
7.7.9.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.7.9.3.Market size and forecast, by End-user, 2016-2026
7.7.9.4.Comparative market share analysis, 2018 &2026
7.7.10.Rest of Asia-Pacific
7.7.10.1.Market size and forecast, by Type, 2016-2026
7.7.10.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.7.10.3.Market size and forecast, by End-user, 2016-2026
7.7.10.4.Comparative market share analysis, 2018 &2026
7.8.LAMEA
7.8.1.1.Market size and forecast, by Type, 2016-2026
7.8.1.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.8.2.Market size and forecast, by End-user, 2016-2026
7.8.3.Market size and forecast, by country, 2016-2026
7.8.4.Comparative market share analysis, 2018 &2026
7.8.5.Latin America
7.8.5.1.Market size and forecast, by Type, 2016-2026
7.8.5.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.8.5.3.Market size and forecast, by End-user, 2016-2026
7.8.5.4.Comparative market share analysis, 2018 &2026
7.8.6.Middle East
7.8.6.1.Market size and forecast, by Type, 2016-2026
7.8.6.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.8.6.3.Market size and forecast, by End-user, 2016-2026
7.8.6.4.Comparative market share analysis, 2018 &2026
7.8.7.Africa
7.8.7.1.Market size and forecast, by Type, 2016-2026
7.8.7.2.Market size and forecast, by Therapeutic Area, 2016-2026
7.8.7.3.Market size and forecast, by End-user, 2016-2026
7.8.7.4.Comparative market share analysis, 2018 &2026
1.Company profiles
1.1.InfineonTechnologies
1.1.1.Business overview
1.1.2.Financial performance
1.1.3.Type portfolio
1.1.4.Recent strategic moves & developments
1.1.5.SWOT analysis
1.2.Mitsubishi
1.2.1.Business overview
1.2.2.Financial performance
1.2.3.Type portfolio
1.2.4.Recent strategic moves & developments
1.2.5.SWOT analysis
1.3. Fuji Electric
1.3.1.Business overview
1.3.2.Financial performance
1.3.3.Type portfolio
1.3.4.Recent strategic moves & developments
1.3.5.SWOT analysis
1.4.Semikron
1.4.1.Business overview
1.4.2.Financial performance
1.4.3.Type portfolio
1.4.4.Recent strategic moves & developments
1.4.5.SWOT analysis
1.5.ON Semiconductors
1.5.1.Business overview
1.5.2.Financial performance
1.5.3.Type portfolio
1.5.4.Recent strategic moves & developments
1.5.5.SWOT analysis
1.6. FairchildSemiconductor
1.6.1.Business overview
1.6.2.Financial performance
1.6.3.Type portfolio
1.6.4.Recent strategic moves & developments
1.6.5.SWOT analysis
1.7.Texas Instruments Incorporated
1.7.1.Business overview
1.7.2.Financial performance
1.7.3.Type portfolio
1.7.4.Recent strategic moves & developments
1.7.5.SWOT analysis
1.8.STMicroelectronics
1.8.1.Business overview
1.8.2.Financial performance
1.8.3.Type portfolio
1.8.4.Recent strategic moves & developments
1.8.5.SWOT analysis
1.9.IXYS
1.9.1.Business overview
1.9.2.Financial performance
1.9.3.Type portfolio
1.9.4.Recent strategic moves & developments
1.9.5.SWOT analysis
1.10.Toshiba
1.10.1.Business overview
1.10.2.Financial performance
1.10.3.Type portfolio
1.10.4.Recent strategic moves & developments
1.10.5.SWOT analysis
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
